Physician profile
Dennis Verducci
NPI 1518466473
$21,632.10
in general payments reported to CMS, 2019-2025
11 companies · $3,677 in 2025
The $3,677 reported for 2025 was more than what 98% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $369 · 2022: $1,262 · 2023: $12K · 2024: $3,843 · 2025: $3,677.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $10K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,730 · Travel and Lodging: $3,427 · Food and Beverage: $2,505.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,340.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,730.00 |
| Travel and Lodging | $3,426.64 |
| Food and Beverage | $2,504.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $13,517.26 | 2023-2025 | |
| Janssen Biotech, INC. | $5,358.96 | 2021-2025 | Darzalex, Tecvayli, Carvykti |
| Adaptive Biotechnologies Corporation | $1,033.54 | 2022-2025 | Clonoseq |
| Genzyme Corporation | $926.99 | 2022-2024 | |
| Karyopharm Therapeutics INC. | $254.25 | 2021 | |
| Legend Biotech USA INC. | $133.94 | 2025 | Carvykti |
| E.R. Squibb & Sons, L.L.C. | $120.97 | 2023 | |
| Janssen Scientific Affairs, LLC | $104.31 | 2023 | Darzalex |
| Glaxosmithkline, LLC. | $100.79 | 2022 | |
| Amgen INC. | $52.14 | 2022 | |
| Celgene Corporation | $28.95 | 2023 | Pomalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Verducci listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.